Administrative Core
行政核心
基本信息
- 批准号:10458537
- 负责人:
- 金额:$ 11.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAsthmaAttentionAwardBiological AssayBiometryBronchiectasisBudgetsChicagoClinicalCollaborationsCommunicationCommunitiesDataData SetDisciplineDoctor of PhilosophyEnsureEnvironmentEpidemiologistEpidemiologyFundingFutureGoalsGovernment AgenciesGrantHuman ResourcesHypersensitivityImmunologistImmunologyIndividualInstitutionInterdisciplinary StudyInternetLinkLung diseasesMaintenanceManuscriptsMedical StudentsMolecularNasal PolypsNatural HistoryOffice of Administrative ManagementOtolaryngologistOutcomePathogenesisPatientsPersonsPhenotypePlayPostdoctoral FellowPreparationProgress ReportsPublicationsRecording of previous eventsReportingResearchResearch PersonnelRoleScholarshipServicesSeveritiesSiteSymptomsSystemTeleconferencesTrainingTranslatingUnited States National Institutes of HealthWomanWorkbasechronic rhinosinusitisclinical phenotypecomorbiditydata handlingdata sharingdisease heterogeneitydoctoral studentinnovationmeetingsmembermenprogramspromotersynergismweb site
项目摘要
ABSTRACT The Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2) is an integrated program of
epidemiologists, otolaryngologists, allergists and immunologists in which highly collaborative studies are
proposed to better understand the molecular and cellular mechanisms of disease heterogeneity and how these
mechanisms translate into clinical phenotypes, natural history and long term outcomes. The program focuses
particular attention to CRS without nasal polyps (CRSsNP), a highly prevalent and yet obscure phenotype from
the standpoint of our current understanding. Another focus of CRISP2 is to critically evaluate the mechanisms
and consequences of comorbid conditions in which patients have both CRS and lung disease such as asthma
or bronchiectasis. Yet another theme is to make inroads in our understanding of why women are more
significantly impacted by CRS than men. In order to achieve these goals, the investigators that comprise the
CRISP2 study team have innovated new assays and approaches to cutting edge studies of pathogenesis and
epidemiology and, most importantly, have merged these two disciplines to relate mechanisms to symptoms,
severity, history and outcomes of CRS.
The Administrative Core (Core A) has as its main functions the goals of providing administrative support
for the vigorous integrative efforts of the program, facilitating communication and data sharing, catalyzing
publications and reporting of the findings of the work, ensuring that the Chronic Rhinosinusitis Integrative
Research Program-2 (CRISP2) promotes an effective training function and organizing the advisory board and
the regular meetings of the CRISP2 participating centers and investigators. Core A is also responsible for the
preparation of progress reports for the program and overseeing regulatory compliance with various institutional
and governmental agencies. Core A will play a central role in promoting synergy and advanced collaborative
interactions in the program. We have organized these and other functions into the following specific aims: 1.)
To provide central administrative services for CRISP2, including oversight of funds distribution, managing the
administrative office, facilitating changes that occur in budget, personnel or scientific direction, overseeing
preparation of progress reports and assurance of appropriate compliance with directives from the NIH, NU, UC,
G/JHU and local, state and federal agencies. The administrative team is Dr. Schleimer (PI), Ms. Valarie Thomas
and Ms. Seletta Nichols (administrators) and Dr. Alfred Rademaker (biostatistician). 2.) To facilitate
communications in CRISP2 and organize an advisory board. CRISP2 will have four quarterly meetings each
year and will maintain an internet-based cloud communications system. 3.) To disseminate discoveries made by
CRISP2. Core A will facilitate manuscript preparation and maintenance of a website. 4.) To encourage training.
Core A will support an ongoing grant program for young scholars. 5.) To promote interdisciplinary research.
Core A will facilitate interactions of the disciplines and individual investigators that are involved in CRISP2.
摘要 慢性鼻窦炎综合研究计划 2 (CRISP2) 是一个综合计划
流行病学家、耳鼻喉科医生、过敏症专家和免疫学家进行高度合作的研究
提出更好地理解疾病异质性的分子和细胞机制以及这些机制如何
机制转化为临床表型、自然史和长期结果。该计划重点
特别关注不伴鼻息肉的慢性鼻窦炎 (CRSsNP),这是一种非常普遍但模糊的表型
我们目前理解的立场。 CRISP2 的另一个重点是批判性地评估机制
以及患者同时患有慢性鼻窦炎和哮喘等肺部疾病的合并症的后果
或支气管扩张。另一个主题是加深我们对为什么女性比男性更重要的理解。
与男性相比,CRS 的影响更为显着。为了实现这些目标,研究人员组成
CRISP2 研究团队创新了新的检测方法和方法,以进行发病机制和疾病的前沿研究。
流行病学,最重要的是,将这两个学科合并起来,将机制与症状联系起来,
CRS 的严重程度、病史和结果。
行政核心(核心 A)的主要职能是提供行政支持
促进该计划的积极综合努力,促进沟通和数据共享,促进
出版物和工作结果报告,确保慢性鼻窦炎综合治疗
研究计划 2 (CRISP2) 促进有效的培训职能并组织顾问委员会和
CRISP2 参与中心和研究者的定期会议。核心 A 还负责
准备该计划的进度报告并监督各机构的监管合规情况
和政府机构。核心A将在促进协同和高级协作方面发挥核心作用
程序中的交互。我们将这些功能和其他功能组织成以下具体目标:1.)
为 CRISP2 提供中央管理服务,包括监督资金分配、管理
行政办公室,促进预算、人事或科学方向发生的变化,监督
准备进度报告并确保适当遵守 NIH、NU、UC、
G/JHU 以及地方、州和联邦机构。管理团队为Schleimer博士(PI)、Valarie Thomas女士
Seletta Nichols 女士(管理员)和 Alfred Rademaker 博士(生物统计学家)。 2.) 促进
在 CRISP2 中进行沟通并组织一个顾问委员会。 CRISP2 每季度召开四次会议
年,并将维护基于互联网的云通信系统。 3.) 传播发现
克里斯普2。核心 A 将有助于手稿的准备和网站的维护。 4.) 鼓励培训。
核心 A 将支持一项针对年轻学者的持续资助计划。 5.) 促进跨学科研究。
核心 A 将促进参与 CRISP2 的学科和个人研究者之间的互动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert P Schleimer其他文献
Robert P Schleimer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert P Schleimer', 18)}}的其他基金
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
- 批准号:
10897481 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
- 批准号:
10897483 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
慢性鼻窦炎综合研究计划 2 (CRISP2)
- 批准号:
10671609 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
慢性鼻窦炎综合研究计划 2 (CRISP2)
- 批准号:
10458536 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
- 批准号:
10458540 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
- 批准号:
10225451 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
CRS中屏障功能障碍和组织增生的机制
- 批准号:
10225449 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - Geisinger
基于人群的 CRS 流行病学:基于临床定义的表型和生物学内型的性别差异、自然史和长期结果 - Geisinger
- 批准号:
10458542 - 财政年份:2019
- 资助金额:
$ 11.38万 - 项目类别:
相似国自然基金
睡眠剥夺通过上调BMAL1/IL-17轴促进三级淋巴结构形成加重哮喘的研究
- 批准号:82300039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于呼吸道菌群失衡介导NLRP3炎症小体激活探讨清肺涤痰治法改善哮喘气道炎症的作用机制
- 批准号:82304934
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ADRA2a调控滤泡辅助性T细胞与生发中心B细胞相互作用参与哮喘发病的机制研究
- 批准号:82370025
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NmU与PGD2协同调控2型免疫反应促进嗜酸性粒细胞型哮喘进程的机制研究
- 批准号:82300024
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Neuropilin-1活化肺2型固有淋巴样细胞促进肺哮喘发生的机制研究
- 批准号:32300727
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Expanding Access to Buprenorphine Treatment among Homeless Persons with Opioid Use Disorder
扩大患有阿片类药物使用障碍的无家可归者获得丁丙诺啡治疗的机会
- 批准号:
10223256 - 财政年份:2020
- 资助金额:
$ 11.38万 - 项目类别:
Enhancing Children's and Parents' Asthma Management
加强儿童和家长的哮喘管理
- 批准号:
8081199 - 财政年份:2010
- 资助金额:
$ 11.38万 - 项目类别:
Hierarchical spatial process models for estimating and predicting health effects
用于估计和预测健康影响的分层空间过程模型
- 批准号:
7943904 - 财政年份:2009
- 资助金额:
$ 11.38万 - 项目类别: